Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure | Charles Explorer

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

Publication at First Faculty of Medicine |

2005

Abstract

eplerenone, acute myocardial infarction

People